Blog

 Figure Gilad Gershon, CEO of Tropic Biosciences The success of the UK in starting and growing biotech companies is well known, but for most people the sector is synonymous only with healthcare and new medicines. Beyond healthcare though, there are other important areas of our lives where biotechnology is making a difference. The agrifood industry […]

read more

SynbiCITE, the UK’s national centre for the commercialisation of synthetic biology, is powering the synthetic biology industry, applying lab-based R&D excellence to fuel the development of tools, products, processes and services for high-value manufacturing industries. SynbiCITE’s four-day MBA course exemplifies this, helping develop the entrepreneurial and management skills in scientists required to run a biotechnology […]

read more

Picture includes Tim Fell CEO at Synthace Oliver Sexton, Investment Director, and Pablo Lubroth, Investment Manager, UKI2S, share their thoughts on the recent SynbiTECH2019 conference in London. The global synthetic biology sector is growing rapidly; 2018 saw 98 synthetic biology companies raise a record $3.8 billion in venture capital, new IPOs, post-equity investments, and secondary market […]

read more

1 2 3 7